(PharmaNewsWire.Com, January 06, 2018 ) The Latin America Biochips Market Market was worth $0.69 billion in 2016 and estimated to be growing at a CAGR of 18.34%, to reach $1.61 billion by 2021. A biochip is a assembly of miniaturized test sites that are organized on a compact substrate, which allows many tests to be executed at the same time to reach higher throughput and speed.
Usually, the surface area of a biochip is no bigger than a fingernail. Like a computer chip that can accomplish millions of mathematical tasks in one second, a biochip can implement thousands of biological responses, such as decoding genes, in the duration of a few seconds.
The growth of the Latin America Biochips Market is mainly driven by factors such as an increased application in cancer study, surge in the utilization of personalized medicine, and increased commercial uses of biochips. However, factors such as an availability of substitute technologies, low commercial suitability due to higher costs, and standardization concerns are restraining the growth of the market in this region.
Market Segmentation o Type • Introduction • DNA Chips o SNP Genotyping o Genomics o Agricultural Biotechnology o Gene Expression o Cancer Diagnosis & Treatment o Drug Discovery o Others • Lab-On-A-Chip o Clinical Diagnostics o IVD & POC o Drug Discovery o Genomics o Proteomics • Protein Chips o Expression Profiling o High-Throughput Screening o Proteomics o Diagnostics o Drug Discovery • Other types o End User • Introduction • Hospitals and Diagnostics Centers • Biotechnology and Pharmaceutical Companies • Academic & Research Institutes o Fabrication Technology • Introduction • Microfluidics • Microarrays
Latin America market region includes countries such as Brazil, Mexico, Argentina, and remaining countries of South America. Brazil is the largest market for Biochips, followed by Mexico, Colombia, and Argentina. With the exception of Brazil and Mexico, the medical regulatory environment in this region is inconsistent when compared to developed countries.
The recent developments in the global biochips market include the outsourcing of biochips technology, which would aid in decreasing labor cost and capital prerequisites. The major companies dominating the Biochips market in this region are Agilent Technologies Inc., Fluidigm Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., GE Healthcare, Cepheid Inc., Illumina Inc., and Thermo Fisher Scientific Inc.
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
